CYTHW

Investor Moves

Investor	Portfolio Value	Portfolio Change	Position Change	Avg Buy Price	Current Price
Ken GriffinCitadel Advisors $-156 TrimQ2 2024 $156 -- --

Trade CYTHW

About Cyclo Therapeutics, Inc.

Cyclo Therapeutics, Inc. is dedicated to developing biopharmaceutical treatments derived from cyclodextrin to combat various illnesses. A central component of their research and development pipeline is Trappsol Cyclo, a therapeutic specifically targeting Niemann-Pick Type C disease and Alzheimer's disease. Charles E. Rick Strattan founded the company on August 9, 1990, and it is presently based in Gainesville, Florida.

CEO: N. Scott Fine
IPO Date: Dec 18, 2020

Market Data

Open: $0.032
High: $0.032
Low: $0.032
Volume: 28.4K
52W High: $0.614
52W Low: $0.025

Valuation

Market Cap: $899k
Enterprise Value: $15M

Financials

Free Cash Flow: $-16M
Revenue: $1.1M
Net Income: $-20M
Cash: $9.2M
Debt: $1.0M

Events

EarningsSep 30

actual -0.29468